Related Experiment Video
Updated: May 24, 2026
06:50
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
AI in multi-omics analysis of type 2 diabetes
Payal Singh1, Md Zubbair Malik2, Swapnil Kumar1
1Data Innovation Center, Sri Innovation and Research Foundation, Ghaziabad, Uttar Pradesh, India.
Summary
Multi-omics integration provides a systems-level view of Type 2 Diabetes pathophysiology. Artificial intelligence (AI) enhances multi-omics data analysis for improved biomarker discovery and personalized diabetes care.
Area of Science:
- Biomedical Research
- Computational Biology
- Genomics and Bioinformatics
Background:
- Type 2 Diabetes (T2D) pathophysiology is complex and multifactorial.
- Traditional single-omics approaches offer limited insights into T2D.
- Multi-omics integration provides a holistic, systems-level understanding of T2D.
Purpose of the Study:
- To explore the integration of multi-omics technologies and artificial intelligence (AI) in understanding Type 2 Diabetes.
- To highlight the challenges and advancements in analyzing high-dimensional multi-omics data.
- To showcase the potential of AI-driven multi-omics for personalized diabetes care.
Main Methods:
- Utilizing multi-omics data integration for comprehensive molecular characterization.
- Applying artificial intelligence (AI), including deep learning, for data analysis and pattern recognition.
- Linking molecular variations across omics layers with clinical phenotypes.
Main Results:
- Multi-omics integration reveals complex molecular interactions and disease pathways in T2D.
- AI effectively addresses analytical challenges posed by high-dimensional, heterogeneous multi-omics data.
- AI-driven multi-omics improves disease risk prediction and patient stratification.
Conclusions:
- The convergence of AI and multi-omics is revolutionizing Type 2 Diabetes research.
- This integration facilitates novel biomarker discovery and the identification of therapeutic targets.
- AI-enhanced multi-omics paves the way for predictive, preventive, and personalized diabetes healthcare.
Keywords:
Artificial intelligenceEpigenomicsGenomicsMachine learningMetabolomicsProteomicsTranscriptomicsType 2 diabetesMore Related Videos
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...